Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AGC Biologics Appoints Boulder Site GM | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

AGC Biologics Appoints Boulder Site GM

David Stewart to oversee the startup, strategic development and operational excellence in large-scale biologics production at the Boulder, CO site.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AGC Biologics, a global biopharmaceutical CDMO, has appointed David Stewart as General Manager/Site Head to oversee the startup, strategic development and operational excellence in large-scale biologics production at its Boulder, CO site.
 
Mr. Stewart brings more than 20 years of leadership experience in the biotechnology and manufacturing industry, including positions with Biogen and Genentech. He will support the continuous growth of the site, while partnering with colleagues across AGC’s global network of facilities to bring new biopharmaceuticals to market.
 
“We are very happy that Mr. Stewart is joining us as General Manager/Site Head for the Boulder Site. He brings broad experience and demonstrated leadership ability from large-scale biologics drug substance operations,” said AGC Biologics Chief Technical Officer, Kasper Møller. “I am confident that Mr. Stewart will lead the Boulder Site to successful operations in support of our customers’ growing demands.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters